NCT04928391View on ClinicalTrials.gov

A Single Bolus of Dexmedetomidine Versus Nalbuphine in Postoperative Agitation

PHASE3RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 20, 2021

Primary Completion Date

February 5, 2027

Study Completion Date

March 20, 2027

Conditions
Cleft Palate
Interventions
DRUG

Dexmedetomidine

A single dose of 0.5 µ/kg IV dexmedetomidine at the end of surgery

DRUG

Nalbuphine

A single dose of 0.1 mg/kg IV nalbuphine at the end of surgery

OTHER

0.9% saline

Same volume of saline placebo IV at the end of surgery

Trial Locations (2)

Assuit universi

RECRUITING

Omar Soliman, Asyut

Unknown

RECRUITING

Assiut university hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER